Hideki Ueno, MD, PhD


Professor
Department of Microbiology
Global Health and Emerging Pathogens Institute
Icahn School of Medicine at Mount Sinai

Professor
Department of Immunology
Graduate School of Medicine, Kyoto University

Primary Investigator
Institute for the Advanced Study of Human Biology, Kyoto University

http://labs.icahn.mssm.edu/uenolab/dr-ueno/


Hideki Ueno, M.D, Ph.D. is a Professor at the Global Health and Emerging Pathogens Institute in the Department of Microbiology. With more than 15 years experience in human immunology, Dr. Ueno’s research focuses on the human adaptive immune system –  the major immunological protection mechanism in charge of generation and maintenance of antigen-specific immune responses. The major research topic in the past decade in the Dr. Ueno Laboratory has been the biology of human T follicular helper (Tfh) cells, a CD4+ T cell subset fundamental for the generation of antibody responses. His laboratory has identified functionally distinct subsets within blood circulating Tfh cells in humans. This seminal work has been cited more than 600 times. This work has led to their identification of cTfh1 cells in charge of antibody responses following seasonal influenza vaccination. The Dr. Ueno laboratory also identified multiple key factors and pathways promoting the differentiation of human Tfh cells, including the IL-12-STAT4 axis.

IDIGH Calendar

<<  <  January 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    1  2  3  4  5
  6  7  8  9101112
13141516171819
202123242526
27283031  

Latest IDIGH Publications

  1. Kunovszki, P., Szántó, K. J., Gimesi-Országh, J., Takács, P., Borsi, A., Bálint, A., Farkas, K., Milassin, Á., Lakatos, P. L., Szamosi, T. & Molnár, T.
    (2020)
    .
    Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016
    .
    Expert opinion on biological therapy
  2. Butler-Laporte, G., Cheng, M. P., McDonald, E. G. & Lee, T. C.
    (2020)
    .
    Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia
    .
    Infection control and hospital epidemiology
    ,
    p
    .
    1-5
    .
  3. Nixon, C. C., Mavigner, M., Sampey, G. C., Brooks, A. D., Spagnuolo, R. A., Irlbeck, D. M., Mattingly, C., Ho, P. T., Schoof, N., Cammon, C. G., Tharp, G. K., Kanke, M., Wang, Z., Cleary, R. A., Upadhyay, A. A., De, C., Wills, S. R., Falcinelli, S. D., Galardi, C., Walum, H., Schramm, N. J., Deutsch, J., Lifson, J. D., Fennessey, C. M., Keele, B. F., Jean, S., Maguire, S., Liao, B., Browne, E. P., Ferris, R. G., Brehm, J. H., Favre, D., Vanderford, T. H., Bosinger, S. E., Jones, C. D., Routy, J.-P., Archin, N. M., Margolis, D. M., Wahl, A., Dunham, R. M., Silvestri, G., Chahroudi, A. & Garcia, J. V.
    (2020)
    .
    Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
    .
    Nature
  4. Deshmukh, H., Rambach, G., Sheppard, D. C., Lee, M., Hagleitner, M., Hermann, M., Würzner, R., Lass-Flörl, C. & Speth, C.
    (2020)
    .
    Galactosaminogalactan secreted from Aspergillus fumigatus and Aspergillus flavus induces platelet activation
    .
    Microbes and infection
  5. Sulis, G. & Pai, M.
    (2020)
    .
    Isoniazid-resistant tuberculosis: A problem we can no longer ignore
    .
    PLoS medicine
    ,
    vol
    .
    17
    ,
    p
    .
    e1003023
    .
More publications